Global Treatment and Diagnosis of Sexually Transmitted Diseases Market 2018 Analysis, Segmentation, Competitors Analysis, Product Research, Trends and Forecast by 2025

Global Treatment and Diagnosis of Sexually Transmitted Diseases Market 2018 Forecast 2025″ report provides 360° view on Industry by shading light on all major factors like Key Players, Demand for Products, End User & Applications, Future Growth & Forecast.

Sexually transmitted infections are asymptomatic and often undiagnosed. Routinely screening and preventive measures are important for early identification, which can prevent severe complications and further transmission. An untreated STD results in several other chronic diseases including pelvic inflammatory disease (PID), infertility, increased risk of HIV and other STDs. There are certain strains of HPV that are linked to cervical, penile, throat and anal cancers. Various types of STDs include:

– Gonorrhea.

– Syphilis.

– Herpes.

– Chlamydia.

– Hepatitis (HBV).

– Human Immunodeficiency Virus (HIV).

– Human Papilloma Virus (HPV or genital warts).

– Chancroid.

– Trichomoniasis.

Download a PDF Sample of this Global Treatment and Diagnosis of Sexually Transmitted Diseases Market Reporthttp://www.orbisresearch.com/contacts/request-sample/2309297

Sexually transmitted infections are spread through sexual contact. These infections are primarily transmitted from one person to another via sexually transmissible bacteria, viruses and parasites. There are several STDs that can be transmitted through tissue transfer, blood products and from mother to child during childbirth or pregnancy. The disease symptoms vary from one person to another; in a few cases there might be no disease symptoms. Symptoms can be mild or acute from one individual to another. There can be severe consequences or long-term complications in individuals suffering from the disease.

A significant proportion of sexually transmitted diseases worldwide is caused by eight major infections: syphilis, chlamydia, gonorrhea, genital herpes, hepatitis B, human papillomavirus (HPV) and trichomoniasis. These diseases have a high prevalence, particularly in developing countries, and it can result in substantial productivity losses for individuals, and communities. In developing countries, sexually transmitted infections are among the leading causes of disability.

Access the complete report with TOC & List of Tables @ http://www.orbisresearch.com/reports/index/global-markets-for-treatment-and-diagnosis-of-sexually-transmitted-diseases

Companies Mentioned:

ABBOTT LABORATORIES

ABBVIE INC.

AGILENT TECHNOLOGIES, INC.

BECTON, DICKINSON AND COMPANY

BIO-RAD LABORATORIES, INC

BIOMERIEUX, INC.

Boehringer Ingelheim Pharmaceuticals, Inc.

BRISTOL-MYERS SQUIBB COMPANY

CEPHEID INC.

GILEAD SCIENCES, INC.

GLAXOSMITHKLINE PLC.

HOFFMANN-LA ROCHE INC.

HOLOGIC INC.

JANSSEN PHARMACEUTICALS, INC.

MERCK & CO., INC.

MERIDIAN LIFE SCIENCE INC.

NOVARTIS AG

PFIZER INC.

PROMEGA CORP.

QIAGEN N.V.

QUIDEL CORP

THERMO FISHER SCIENTIFIC, INC.

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Information Sources

Methodology

Geographic Breakdown

Analyst’s Credentials

BCC Custom Research

Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Global Market Overview and Trends

Overview of Sexually Transmitted Diseases and Definitions

Sexually Transmitted Diseases and Pregnancy

Screening Programs and Guidelines

Mobile HIV Testing in Brazil

Benzathine Penicillin Drug Shortage

Trends in Global Transmission of STDs

Increasing Incidence of STDs

STD Awareness and Screening Services

Development of Test Kits with High Sensitivity for Low Resource Settings

Challenges

Underestimating the Risk of Contracting the Disease

Social Stigma Associated with STDs

Rising Incidence of Antibiotic Resistance

Lack of Prenatal Screening for STDs

Chapter 4 Disease Overview

Introduction

Chlamydia

Overview

Epidemiology

Diagnosis

Treatments

Genital Herpes

Overview

Epidemiology

Diagnosis

Treatments

Gonorrhea

Overview

Epidemiology

Diagnosis

Treatments

Hepatitis A, B and C

Overview

Epidemiology

Diagnosis

Treatments

Market Size

HIV/AIDS

Overview

Epidemiology

Diagnosis

Treatments

Market Size and Forecast

HPV

Overview

Diagnosis

Treatments

Syphilis

Overview

Epidemiology

Diagnosis

Treatments

Others

Overview

Market Analysis

Chapter 5 STD Diagnosis and Treatment Options

Introduction to STD Diagnostics, by Test Type

Enzyme Immunoassay (EIA) and ELISA

Polymerase Chain Reaction (PCR)

Rapid Diagnostics Tests (RDTs)

Others

Introduction to Treatment by Drug Class

Antibiotics/Antibacterial

Antiviral/ Antiretrovirals

Others

Chapter 6 The North American Market Breakdown

Overview of North American Market

United States

Canada

Mexico

Chapter 7 The European Market Breakdown

Overview of the European Market

Chlamydia

United Kingdom

Germany

France

Spain

Italy

Rest of Europe

Chapter 8 The Asia-Pacific Market Breakdown

Overview of The Asia-Pacific Market

Market Analysis

Key Trends in STI Prevention

Legal Obstructions

Social Stigma and Discrimination

China

Prevention Programs

Legal and Punitive Barriers

Market Analysis

Japan

Chlamydia

Genital Herpes

Gonorrhea

Syphilis

Market Analysis

India

Launch of Hepcinat Plus for Hepatitis C in India

Aurobindo Pharma Files for Dolutegravir Generic

Market Analysis

South Korea

Market Analysis

Rest of Asia-Pacific

HIV/AIDS

Market Analysis

Chapter 9 Rest of World Market Breakdown

The Rest of World Overview

South American Market Overview

Middle East and Africa Overview

Chapter 10 Regulatory Structure

Overview of Regulations

United States

Europe

Japan

China

Overview of Pricing and Reimbursement

United States

Europe

Japan

Chapter 11 Pipeline Analysis

HIV Pipeline Overview

List of Drugs in HIV Pipeline

Hepatitis C Pipeline Overview

Several Drug Combinations Discontinued

Gonorrhea Pipeline Overview

Late-Stage Pipeline Molecules

Doravirine (MK-1439, DOR)

Drugs to Gain Marketing Authorization

Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide)

Dolutegravir/Lamivudine (ViiV Healthcare)

Aikening (albuvirtide for injection) (Frontier Biotechnology Inc.)

Elpida (elsulfavirine) (Viriom, Inc.)

Isentress HD (Raltegravir) (Merck & Co., Inc.)

Chapter 12 Competitive Landscape and Key Developments

Market Structure Analysis

Patent Analysis

Key Developments

Mergers and Acquisitions

Development of Innovative Products/Novel Product Launches

Agreement, Collaboration and Partnerships

Chapter 13 Company Profiles

ABBOTT LABORATORIES

Company Overview

Product Information

Development and Strategies

Financials

ABBVIE INC.

Company Overview

Product Information

Development and Strategies

Financials

AGILENT TECHNOLOGIES, INC.

Company Overview

Financials

BECTON, DICKINSON AND COMPANY

Company Overview

Product Information

Key Developments and Strategies

Financials

BIOMERIEUX, INC.

Company Overview

Product Information

BIO-RAD LABORATORIES, INC

Company Overview

Product Information

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Company Overview

Financials

Development and Strategies

BRISTOL-MYERS SQUIBB COMPANY

Company Overview

Product Information

Financials

CEPHEID INC.

Company Overview

GILEAD SCIENCES, INC.

Company Overview

Product Information

Development and Strategies

Financials

GLAXOSMITHKLINE PLC.

Company Overview

Product Information

Development and Strategies

Financials

HOFFMANN-LA ROCHE INC.

Company Overview

Product Information

Development and Strategies

Financials

HOLOGIC INC.

Company Overview

Product Information

Financials

JANSSEN PHARMACEUTICALS, INC.

Company Overview

Product Information

Developments and Strategies

Financials

MERCK & CO., INC.

Company Overview

Product Information

Development and Strategies

Financials

MERIDIAN LIFE SCIENCE INC.

Company Overview

Product Information

NOVARTIS AG

Company Overview

Product Information

Financials

PFIZER INC.

Company Overview

Product Information

Development and Strategies

Financials

PROMEGA CORP.

Company Overview

QIAGEN N.V.

Company Overview

Product Information

Development and Strategies

Financials

QUIDEL CORP

Company Overview

Product Information

THERMO FISHER SCIENTIFIC, INC.

Company Overview

Product Information

Financials

Chapter 14 Appendix: Abbreviations

Abbreviations

 

About Orbis Research

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.